I fatti · Mito del suicidio
La minaccia del suicidio è la tattica numero uno che medici attivisti, politici e organismi medici usano da anni per comprare sostegno alla transizione dei bambini.
Ai genitori viene persino detto che possono avere una figlia morta o un figlio vivo. Questa è manipolazione coercitiva e una menzogna spregevole.
I fatti ci sono. Il suicidio compiuto è per fortuna raro, e non è stato dimostrato che la transizione medica pediatrica prevenga il suicidio.
Leggi il grafico, non un muro di link. Gli studi sui giovani non sono studi sugli adulti. Un’indagine sui tentativi di suicidio non è un conteggio delle morti per suicidio.
News — Supreme Court exchange
In U.S. v. Skrmetti oral argument (Dec 4, 2024), ACLU attorney Chase Strangio told Justice Alito there is no evidence in the studies that gender-affirming treatment reduces completed suicide, and that completed suicide is “thankfully and admittedly” rare — while distinguishing that from “suicidality.”
Risultati legati al suicidio di Biggs (2022), Van Cauwenberg (2021), Ruuska (2024), Do No Harm, Cass, HHS e Dhejne 2011
Studio
Tavistock GIDS referrals, 2010–2020.
Risultato
Among ~15,032 youth referred to Tavistock GIDS (2010–2020), 4 suicides — completed suicide rare in absolute terms (HHS Table 4.1: 0.03%, 0.13 per 1K patient-years).
Studio
Belgian pediatric gender clinic cohort.
Risultato
Belgian pediatric gender clinic cohort; 5 suicides among referred youths (HHS Table 4.1: 3.38%, 11.26 per 1K patient-years); HHS notes all suicides among patients taking cross-sex hormones.
Studio
Youth and young adults under 23 referred to Finnish gender services, 1996–2019: 2,083 people vs 16,643 matched controls.
Risultato
Suicide deaths were uncommon (0.3% vs 0.1% in matched peers) and, once specialist psychiatric treatment was accounted for, not statistically different; medical gender reassignment was not shown to change suicide risk.
Studio
New — 17 September 2026
CDC teen suicide rates after state bans on puberty blockers, opposite-sex hormones, and surgeries for minors. Jay Greene, Ph.D. and Ian Kingsbury, Ph.D. for Do No Harm. Three models: difference-in-differences, Callaway–Sant’Anna DiD, and a national time-series.
Risultato
Do No Harm analyzed CDC teen suicide rates after state bans on puberty blockers, opposite-sex hormones, and surgeries for minors. Across three models (difference-in-differences, Callaway–Sant’Anna DiD, and a national time-series), there was no statistically significant increase in teen suicide rates. The claim that these bans cause a spike in teen suicides is not supported by the data.
Studio
Independent review of NHS gender identity services for children and young people, underpinned by University of York systematic reviews.
Risultato
The evidence does not support the claim that hormone treatment reduces the elevated risk of death by suicide in this population.
Studio
U.S. Department of Health and Human Services review of treatment for pediatric gender dysphoria. The suicide points on this chart are from that review.
Risultato
There is no evidence that pediatric medical transition reduces suicide deaths, which remain very low; completed suicide among adolescents with gender dysphoria is rare, and suicidality tracks with other mental-health conditions rather than with gender dysphoria alone.
Studio
Adults. All 324 people in Sweden who had sex-reassignment surgery, 1973–2003, compared with matched population controls.
Risultato
After sex reassignment / surgical transition, suicide deaths were about 19.1 times higher than among matched peers (adjusted hazard ratio 19.1). Transition did not bring suicide mortality in line with the general population — the elevated suicide risk remained after transition.
La vecchia pagina web del GIDS “Evidence base” non c’è più, quindi non è una fonte qui. Il follow-up ufficiale del Regno Unito è il rapporto Appleby del 2024 sui suicidi del Tavistock / GIDS: i dati non sostengono un forte aumento dopo che i bloccanti della pubertà sono stati limitati. Appleby 2024 — Tavistock / GIDS suicides (GOV.UK) →
Iscriviti. Ricevi gli aggiornamenti.
Scegli un aggiornamento quotidiano, un riepilogo settimanale o entrambi.